APA

Kendall M. A., Andersen J. W. & van der Horst C. (20061026). A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207. : Contemporary clinical trials.

Chicago

Kendall Michelle A, Andersen Janet W and van der Horst Charles. 20061026. A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207. : Contemporary clinical trials.

Harvard

Kendall M. A., Andersen J. W. and van der Horst C. (20061026). A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207. : Contemporary clinical trials.

MLA

Kendall Michelle A, Andersen Janet W and van der Horst Charles. A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207. : Contemporary clinical trials. 20061026.